Skip to main content
TipRanks
Go Ultimate75% OFF

Caryn Gordon McDowell Insider Profile

4 Followers

Caryn Gordon McDowell, Chief Legal & Adm. Officer at IRulya Therapeutics, holds 122.50K shares in IRulya Therapeutics (Ticker: IRLA), holds 23.45K shares in Revance Therapeutics (Ticker: RVNC), holds 32.55K shares in Cytokinetics (Ticker: CYTK).

Caryn Gordon McDowell's Trading History

IRLA
IRulya Therapeutics
Jun 08, 2022Chief Legal & Adm. OfficerUninformative Sell19.16K$3.80M
RVNC
Revance Therapeutics
Feb 19, 2020―Uninformative Sell21.89K$85.60K
CYTK
Cytokinetics
Mar 01, 2018GC & Chief Compliance OfficerUninformative Buy―$1.75M

You May Also Like

Caryn Gordon McDowell insider profile FAQ

What stocks does Caryn Gordon McDowell hold?
Caryn Gordon McDowell holds: IRLA, CYTK, RVNC stocks.
What was Caryn Gordon McDowell’s latest transaction?
Caryn Gordon McDowell’s latest transaction was an Uninformative Sell of $19.16K.
What is Caryn Gordon McDowell's role in IRulya Therapeutics?
Caryn Gordon McDowell's role in IRulya Therapeutics is Chief Legal & Adm. Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.